Tuesday, July 31, 2012

Kidney International Supplements - Table of Contents alert Volume 2 Issue 4


KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease


KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Belo Foundation, Coca-Cola Company, Dole Food Company, Genzyme, Hoffmann-LaRoche, JC Penney, NATCO-The Organization for Transplant Professionals, NKF-Board of Directors, Novartis, Robert and Jane Cizik Foundation, Shire, Transwestern Commercial Services, and Wyeth.

TABLE OF CONTENTS

Volume 2, Issue 4 (August 2012)

In this issue
Preface
Contents
Appendix


Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement

Articles for Kidney International are published online ahead of print through Advance Online Publication (AOP), meaning that the latest research reaches you in the timeliest way possible. Check the AOP webpage each week to make sure that you are not left behind.

 

Preface

Top

Notice

Kidney inter., Suppl. 2012 2: 279; 10.1038/kisup.2012.37

Full Text | PDF

Foreword

Kidney inter., Suppl. 2012 2: 280; 10.1038/kisup.2012.38

Full Text | PDF

Work Group Membership

Kidney inter., Suppl. 2012 2: 281; 10.1038/kisup.2012.39

Full Text | PDF

Abstract

Kidney inter., Suppl. 2012 2: 282; 10.1038/kisup.2012.40

Full Text | PDF

Summary of Recommendation Statements

Kidney inter., Suppl. 2012 2: 283-287; 10.1038/kisup.2012.41

Full Text | PDF

Contents

Top

Chapter 1: Diagnosis and evaluation of anemia in CKD

Kidney inter., Suppl. 2012 2: 288-291; 10.1038/kisup.2012.33

Full Text | PDF

Chapter 2: Use of iron to treat anemia in CKD

Kidney inter., Suppl. 2012 2: 292-298; 10.1038/kisup.2012.34

Full Text | PDF

Chapter 3: Use of ESAs and other agents to treat anemia in CKD

Kidney inter., Suppl. 2012 2: 299-310; 10.1038/kisup.2012.35

Full Text | PDF

Chapter 4: Red cell transfusion to treat anemia in CKD

Kidney inter., Suppl. 2012 2: 311-316; 10.1038/kisup.2012.36

Full Text | PDF

Appendix

Top

Methods for guideline development

Kidney inter., Suppl. 2012 2: 317-323; 10.1038/kisup.2012.42

Full Text | PDF

Biographic and Disclosure Information

Kidney inter., Suppl. 2012 2: 324-329; 10.1038/kisup.2012.43

Full Text | PDF

Acknowledgments

Kidney inter., Suppl. 2012 2: 330; 10.1038/kisup.2012.44

Full Text | PDF

References

Kidney inter., Suppl. 2012 2: 331-335; 10.1038/kisup.2012.45

Full Text | PDF

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Kidney International Supplements. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: